No Data
No Data
Cochlear (ASX:COH) May Have Issues Allocating Its Capital
Cochlear Receives FDA Clearance to Lower the Age for the Osia System to 5-years-old
In the United States, the Osia System is now cleared for children ages 5 and older The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed h
Institutions Along With Retail Investors Who Hold Considerable Shares InCochlear Limited (ASX:COH) Come Under Pressure; Lose 3.3% of Holdings Value
Competition Regulator Clears Cochlear's Acquisition of Oticon Medical's Cochlear Implant Business
The Australian Competition and Consumer Commission on Thursday said that it is not opposing Cochlear's (ASX:COH) proposed acquisition of Oticon Medical's cochlear implant business, according to a fili
Cochlear's Oticon Implants Acquisition Approved by Australian Regulator
By Stuart Condie SYDNEY--Cochlear's acquisition of Oticon Medical's cochlear implants business was approved by Australia's competition regulator following removal of the Danish company's bone-conduct
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
No Data